In a decision expected to send a chill through the booming stem cell industry, a federal judge ruled in favor of the Food and Drug Administration on Monday in a lawsuit against a Florida-based stem cell company whose treatments have blinded at least four patients

Quick Read

ISSCR, an international stem-cell body says the country’s proposed law could put patients at risk

Quick Read

The military is constantly using technology to build better ships, warplanes, guns and armor. Shouldn’t it also use drugs to build better soldiers?

Quick Read

The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

“2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense,” says Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley

Quick Read

A procedure called mitochondrial replacement therapy could eliminate devastating diseases. It would not enable parents to ‘design’ their children

Quick Read

Stanford is investigating Stephen Quake, a professor of biotechnology, because of his interaction with He Jiankui, the scientist behind the first gene-edited babies. “I hold myself to high ethical standards,” said Dr. Quake, who was once Dr. He’s academic adviser

Quick Read